Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome

Journal of Nutritional Biochemistry

Volumn 23, Issue 3, 2012, Pages 239-244

  Phillips, Catherine M ^a   Goumidi, Louisa ^b   Bertrais, Sandrine ^c   Field, Martyn R ^d   McManus, Ross ^e   Hercberg, Serge ^c   Lairon, Denis ^b   Planells, Richard ^b   Roche, Helen M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b INSERM   (France)

^c Université Paris 13 ^*  (France)

^d Hitachi Dublin Laboratory   (Ireland)

^e TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Gene diet interaction; Insulin sensitivity; LIPGENE; Metabolic syndrome; Saturated fat; TCF7L2

Indexed keywords

INSULIN; SATURATED FATTY ACID; TRANSCRIPTION FACTOR 7 LIKE 2;

ABDOMINAL OBESITY; ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE EXACERBATION; FAT INTAKE; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SEX DIFFERENCE;

ALLELES; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIET; DIETARY FATS; DNA; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; INSULIN; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84855300255     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.11.020     Document Type: Article

References (42)

1. Moller D.E., Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005, 56:45-62.
2. Florez J.C., Jablonski K.A., Bayley N., Pollin T.I., de Bakker P.I., Shuldiner A.R., et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006, 355(3):241-250.
3. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38(3):320-323.
4. Cauchi S., El Achhab Y., Choquet H., Dina C., Krempler F., Weitgasser R., et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med (Berlin, Germany) 2007, 85(7):777-782.
5. Cauchi S., Meyre D., Dina C., Choquet H., Samson C., Gallina S., et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006, 55(10):2903-2908.
6. Chandak G.R., Janipalli C.S., Bhaskar S., Kulkarni S.R., Mohankrishna P., Hattersley A.T., et al. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 2007, 50(1):63-67.
7. Hayashi T., Iwamoto Y., Kaku K., Hirose H., Maeda S. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia 2007, 50(5):980-984.
8. Humphries S.E., Gable D., Cooper J.A., Ireland H., Stephens J.W., Hurel S.J., et al. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. Journal of molecular medicine (Berlin. Germany) 2006, 84(12 Suppl):1-10.
9. Wang J., Kuusisto J., Vanttinen M., Kuulasmaa T., Lindstrom J., Tuomilehto J., et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 2007, 50(6):1192-1200.
10. Melzer D., Murray A., Hurst A.J., Weedon M.N., Bandinelli S., Corsi A.M., et al. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med 2006, 4:34.
11. Warodomwichit D., Arnett D.K., Kabagambe E.K., Tsai M.Y., Hixson J.E., Straka R.J., et al. Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia. J Nutr 2009, 139(3):439-446.
12. Sjogren M., Lyssenko V., Jonsson A., Berglund G., Nilsson P., Groop L., et al. The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia 2008, 51(12):2242-2251.
13. Marzi C., Huth C., Kolz M., Grallert H., Meisinger C., Wichmann H.E., et al. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm Metab Res 2007, 39(1):46-52.
14. Saadi H., Nagelkerke N., Carruthers S.G., Benedict S., Abdulkhalek S., Reed R., et al. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects. Diabetes Res Clin Pract 2008, 80(3):392-398.
15. Kabagambe E.K., Tsai M.Y., Hopkins P.N., Ordovas J.M., Peacock J.M., Borecki I.B., et al. Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin Chem 2008, 54(1):154-162.
16. Phillips C., Lopez-Miranda J., Perez-Jimenez F., McManus R., Roche H.M. Genetic and nutrient determinants of the metabolic syndrome. Curr Opin Cardiol 2006, 21(3):185-193.
17. Szabo de Edelenyi F., Goumidi L., Bertrais S., Phillips C., Macmanus R., Roche H., et al. Prediction of the metabolic syndrome status based on dietary and genetic parameters, using Random Forest. Genes Nutr 2008, 3(3):173-176.
18. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003, 14(1):15-19.
19. Warensjo E., Riserus U., Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005, 48(10):1999-2005.
20. Warensjo E., Sundstrom J., Lind L., Vessby B. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 2006, 84(2):442-448.
21. Storlien L.H., Baur L.A., Kriketos A.D., Pan D.A., Cooney G.J., Jenkins A.B., et al. Dietary fats and insulin action. Diabetologia 1996, 39(6):621-631.
22. van Dam R.M., Willett W.C., Rimm E.B., Stampfer M.J., Hu F.B. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002, 25(3):417-424.
23. Perez-Jimenez F., Lopez-Miranda J., Pinillos M.D., Gomez P., Paz-Rojas E., Montilla P., et al. A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia 2001, 44(11):2038-2043.
24. Vessby B., Unsitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia 2001, 44(3):312-319.
25. Bos M.B., de Vries J.H., Feskens E.J., van Dijk S.J., Hoelen D.W., Siebelink E., et al. Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity. Nutr Metab Cardiovasc Dis 2010, 20:591-598.
26. Lovejoy J.C., Smith S.R., Champagne C.M., Most M.M., Lefevre M., DeLany J.P., et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes care 2002, 25(8):1283-1288.
27. Mayer-Davis E.J., Monaco J.H., Hoen H.M., Carmichael S., Vitolins M.Z., Rewers M.J., et al. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS). Am J Clin Nutr 1997, 65(1):79-87.
28. Hercberg S., Galan P., Preziosi P., Bertrais S., Mennen L., Malvy D., et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004, 164(21):2335-2342.
29. Le Moullec N.D.M., Preziosi P., et al. Validation du manuel-photos utilisé pour l'enquête alimentaire de l'étude SU.VI.MAX. Cah Nutr Diet 1996, 31:158-164.
30. Feinberg M., Favier J.C., Répertoire général des aliments J.I.R. Fondation Française pour la Nutrition; Centre Informatique sur la Qualité des Aliments 1991, Institut National de la Recherche Agronomique, Technique et Documentation-Lavoisier.
31. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Jama 2001, 285(19):2486-2497.
32. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
33. Perseghin G., Caumo A., Caloni M., Testolin G., Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 2001, 86(10):4776-4781.
34. Phillips C.M., Goumidi L., Bertrais S., Ferguson J.F., Field M.R., Kelly E.D., et al. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am J Clin Nutr 2009.
35. Liang K.Y., Zeger S.L. Regression analysis for correlated data. Annu Rev Public Health 1993, 14:43-68.
36. Laramie J.M., Wilk J.B., Williamson S.L., Nagle M.W., Latourelle J.C., Tobin J.E., et al. Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with type 2 diabetes and fasting glucose; the NHLBI Family Heart Study. BMC Med Genet 2008, 9:46.
37. Brunner E.J., Wunsch H., Marmot M.G. What is an optimal diet? Relationship of macronutrient intake to obesity, glucose tolerance, lipoprotein cholesterol levels and the metabolic syndrome in the Whitehall II study. Int J Obes Relat Metab Disord 2001 Jan, 25(1):45-53.
38. Kimber C.H., Doney A.S., Pearson E.R., McCarthy M.I., Hattersley A.T., Leese G.P., et al. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia 2007, 50(6):1186-1191.
39. Pearson E.R., Donnelly L.A., Kimber C., Whitley A., Doney A.S., McCarthy M.I., et al. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes 2007, 56(8):2178-2182.
40. Damcott C.M., Pollin T.I., Reinhart L.J., Ott S.H., Shen H., Silver K.D., et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006, 55(9):2654-2659.
41. Lyssenko V., Lupi R., Marchetti P., Del Guerra S., Orho-Melander M., Almgren P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007, 117(8):2155-2163.
42. Yuan H.Y., Chiou J.J., Tseng W.H., Liu C.H., Liu C.K., Lin Y.J., et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006, 34(Web Server issue):W635-W641.